Pourcelot et al. described slightly increased levels of IL-12 in the MPN subgroups with vascular complications, but when the analysis was performed for each disease category (PV and ET), surprisingly, IL-12 and GM-CSF were increased in patients without complications [71]. This evidence concerns the gene CSF2 and acquired polycythemia vera.